DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Omniscan (Gadodiamide) - Anxiety - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anxiety (85)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) where reactions include anxiety. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 85   Next >>

Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Mobility Decreased, Extremity Contracture

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Magnevist

Other drugs received by patient: Hectorol; Coumadin; Metoclopramide; Aspirin; Klor-CON



Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: male

Reactions: Pain, Abasia, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Grip Strength Decreased, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-11-13

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Renal Transplant

Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: male

Reactions: Abasia, Pain, Joint Contracture, Sensory Loss, Skin Hyperpigmentation, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Muscle Contracture, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Limb Discomfort, Grip Strength Decreased, Mobility Decreased, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Renal Transplant

Other drugs received by patient: Metoclopramide; Klor-CON; Hectorol; Coumadin; Aspirin



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: male

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Anhedonia, Balance Disorder, Skin Lesion, Depression, Extremity Contracture, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist

Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2006-11-13

Other drugs received by patient: Coumadin; Aspirin; Klor-CON; Metoclopramide; Hectorol



Possible Omniscan side effects in male

Reported by a lawyer from United States on 2012-08-01

Patient: male

Reactions: Quality of Life Decreased, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Deformity, Anxiety, Emotional Distress, Fibrosis, Injury, Scar, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Start date: 2004-11-23

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2003-05-10

Omniscan
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-06-25

Omniscan
    Dosage: unk
    Start date: 2004-10-15

Omniscan
    Dosage: unk
    Start date: 2004-10-04

Omniscan
    Dosage: unk
    Start date: 2005-03-18



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: female

Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging



Possible Omniscan side effects in 79 year old female

Reported by a physician from United States on 2012-07-20

Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia

Adverse event resulted in: death

Drug(s) suspected as cause:
Omniscan
    Dosage: dose reported as eight 20ml vials (160ml)
    Start date: 2005-09-20
    End date: 2005-09-20

Multihance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Multihance
    Indication: Angiogram

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Gadolinium Zeolite
    Start date: 2005-08-16
    End date: 2005-08-16

Omniscan
    Dosage: route reported as ^first via distal port and then via the proximal port^
    Indication: Angiogram
    Start date: 2003-12-04
    End date: 2003-12-04

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2005-08-16
    End date: 2005-08-16

Optimark
    Indication: Angiogram

Gadolinium Zeolite
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-05
    End date: 2001-03-05

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-05-23
    End date: 2003-05-23

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: dose reported as ^11^ 20ml vials
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar



Possible Omniscan side effects in 44 year old female

Reported by a physician from United States on 2012-07-18

Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)

Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased

Drug(s) suspected as cause:
Optimark

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-02-06

Optimark
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-05-31

Optimark
    Dosage: unk
    Start date: 2005-08-31

Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc



Possible Omniscan side effects in 51 year old female

Reported by a lawyer from United States on 2012-07-09

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Fistulogram

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Optimark
    Indication: Venogram

Multihance
    Indication: Venogram

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Prohance
    Indication: Venogram

Prohance
    Indication: Fistulogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Magnevist
    Indication: Dialysis Device Insertion

Omniscan
    Indication: Fistulogram

Optimark
    Indication: Fistulogram

Omniscan
    Indication: Venogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-06

Patient: female

Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Multihance
    Indication: Angiogram

Prohance
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging



Possible Omniscan side effects in 58 year old female

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, unk
    Indication: Imaging Procedure
    Start date: 2003-12-20

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-05-26
    End date: 2005-05-26

Prohance
    Indication: Imaging Procedure

Magnevist
    Dosage: 15 ml, unk
    Indication: Angiogram
    Start date: 2006-05-30

Omniscan
    Indication: Imaging Procedure

Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps



Possible Omniscan side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13

Patient: 35 year old female, weighing 79.5 kg (174.8 pounds)

Reactions: Anxiety, Dyspnoea, Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Omniscan
    Indication: Migraine
    Start date: 2012-05-09
    End date: 2012-05-09

Omniscan
    Indication: Multiple Sclerosis

Omniscan
    Indication: Diagnostic Procedure



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax



Possible Omniscan side effects in 51 year old female

Reported by a lawyer from United States on 2012-05-31

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Omniscan
    Indication: Venogram

Optimark
    Indication: Venogram

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Magnevist
    Indication: Dialysis Device Insertion

Multihance
    Indication: Fistulogram

Prohance
    Indication: Fistulogram

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Fistulogram

Prohance
    Indication: Venogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Fistulogram

Multihance
    Indication: Venogram

Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Omniscan
    Dosage: unk

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-25

Patient: female

Reactions: Anxiety, Emotional Distress, Pain, Injury, Fibrosis, Nephrogenic Systemic Fibrosis, Deformity, Disability

Drug(s) suspected as cause:
Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Magnevist
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Prohance
    Indication: Angiogram



Possible Omniscan side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 62 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Erythema, Rash Pruritic, Skin Ulcer, Skin Lesion, Oedema Peripheral, Skin Atrophy, Pain in Extremity, Pain of Skin, Skin Disorder, Rash, Hypoaesthesia, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Plaque, Burning Sensation, Emotional Distress, Anxiety, Exfoliative Rash, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-17
    End date: 2006-01-17

Omniscan
    Dosage: 40 ml, then 50 ml
    Indication: Angiogram
    Start date: 2004-11-09
    End date: 2004-11-09

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Gabapentin; Renagel; Hydrochlorothiazide; Dalteparin Sodium; Magnesium; Epogen; Carvedilol; Atenolol; Lyrica; Calcium; Benicar; Folic Acid; Simvastatin; Hydralazine HCL; Aranesp; Mirtazapine; Codeine Sulfate; Norvasc; Darvocet; Renagel; Metoprolol; Furosemide; Renagel; Doxazosin Mesylate



Possible Omniscan side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14

Patient: 64 year old male

Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Skin Lesion, Injury, Mobility Decreased

Drug(s) suspected as cause:
Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Omniscan
    Start date: 2003-02-27
    End date: 2003-02-27

Magnevist
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Magnevist
    Start date: 2003-02-27
    End date: 2003-02-27

Prohance
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Product Used FOR Unknown Indication

Multihance
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Lanoxin; Coumadin; Nitroglycerin; Metoprolol Tartrate



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-11

Patient: female

Reactions: Anxiety, Emotional Distress, Pain, Nephrogenic Systemic Fibrosis, Injury

Drug(s) suspected as cause:
Optimark

Magnevist

Omniscan



Possible Omniscan side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Erythema, Upper Extremity Mass, Joint Stiffness, Muscle Fatigue, Proteinuria, Oedema Peripheral, Renal Cortical Necrosis, Pain in Extremity, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Stress, Emotional Distress, Rash Erythematous, Scar, Soft Tissue Disorder, Pain, Skin Hyperpigmentation, Myosclerosis, Skin Discolouration, Joint Range of Motion Decreased, Oedema, Musculoskeletal Stiffness, Injury, Renal Failure Acute, Musculoskeletal Pain, Rash Papular, Skin Disorder, Renal Failure Chronic, Burning Sensation, Anxiety, Dysstasia, Limb Discomfort, Arthralgia, Renal Tubular Necrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-10-01

Magnevist
    Dosage: daily dose 20 ml
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2007-09-05
    End date: 2007-09-05

Optimark

Multihance

Magnevist
    Dosage: unk
    Start date: 2005-05-26

Omniscan

Magnevist
    Dosage: unk
    Start date: 2004-10-07

Omnipaque 140
    Dosage: 150 ml, unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-09-30
    End date: 2004-09-30

Hypaque-M [meglumine Amidotrizoate]
    Dosage: unk
    Administration route: Oral
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-06
    End date: 2004-10-06

Prohance

Magnevist
    Dosage: unk
    Start date: 2005-05-09

Magnevist
    Dosage: unk
    Start date: 2004-11-18

Magnevist
    Dosage: unk
    Start date: 2005-05-23

Other drugs received by patient: Cytoxan; Xanax; Sensipar; Ferrous Sulfate TAB; Contrast Media; Immune Globulin NOS; Gabapentin; Valcyte; Contrast Media; Prednisone; Lasix; Marijuana; Midodrine Hydrochloride; Lisinopril; Aspirin; Norvasc; Cyclobenzaprine; Calcium +vit D; Coumadin; Contrast Media; Lopressor; Epogen; Cellcept; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Gengraf; Renagel



Possible Omniscan side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 62 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Hyperkeratosis, Pruritus, Pain, Erythema, Rash Pruritic, Skin Ulcer, Oedema Peripheral, Skin Lesion, Skin Atrophy, Pain in Extremity, Pain of Skin, Skin Disorder, Skin Hypertrophy, DRY Skin, Hypoaesthesia, Skin Induration, Rash, Nephrogenic Systemic Fibrosis, Skin Plaque, Emotional Distress, Burning Sensation, Anxiety, Exfoliative Rash, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-17
    End date: 2006-01-17

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 40 ml, then 50 ml
    Indication: Angiogram
    Start date: 2004-11-09
    End date: 2004-11-09

Other drugs received by patient: Norvasc; Folic Acid; Hydrochlorothiazide; Dalteparin Sodium; Hydralazine HCL; Calcium; Epogen; Gabapentin; Furosemide; Darvocet; Renagel; Carvedilol; Benicar; Simvastatin; Lyrica; Magnesium; Renagel; Aranesp; Metoprolol Tartrate; Doxazosin Mesylate; Atenolol; Mirtazapine; Codeine SUL TAB



Possible Omniscan side effects in 31 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 31 year old female, weighing 59.8 kg (131.6 pounds)

Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Muscle Spasticity, Joint Stiffness, Myalgia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, Muscle Contracture, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Stress, Skin Tightness, Finger Deformity, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Multihance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-01-10
    End date: 2003-01-10

Prohance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Brain

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2007-01-18
    End date: 2007-01-18

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-22
    End date: 2003-09-22

Other drugs received by patient: Amlodipine Besylate; Accupril; Ibuprofen; Renagel; Cardura; Depakote; Amiodarone HCL; Elavil; Pravastatin; Labetalol HCL; Phenytoin; Aspirin; Metoprolol Tartrate; Morphine; Plendil; Lovenox; Methadone HCL; Lidocaine; Vitamin K TAB; Clonidine; Heparin; Lamictal; Folic Acid; Enoxaparin; Promethazine; Norvasc; Cardizem; Coumadin; Prednisone TAB; Diazepam; Dilantin; Vicodin; Xanax



Possible Omniscan side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: 52 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Soft Tissue Disorder, Joint Contracture, Abasia, Pain, Skin Hyperpigmentation, Muscle Fibrosis, Joint Stiffness, Myosclerosis, Calcification of Muscle, Skin Discolouration, Impaired Self-Care, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Unevaluable Event, Extremity Contracture, Skin Disorder, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Induration, Stress, Amnesia, Skin Plaque, Anxiety, Dysphonia, Skin Fibrosis, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 1999-05-14
    End date: 1999-05-14

Omniscan
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2001-07-20
    End date: 2001-07-20

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 2003-09-09
    End date: 2003-09-09

Omniscan
    Dosage: 0.15 mmol/kg
    Start date: 2000-04-18
    End date: 2000-04-18

Omniscan
    Dosage: 30 ml, once
    Indication: Venogram
    Start date: 2000-10-19
    End date: 2000-10-19

Omniscan
    Dosage: 0.1 mmol/kg, unk
    Start date: 2003-10-20
    End date: 2003-10-20

Omniscan
    Dosage: 40 ml, once
    Start date: 2001-10-16
    End date: 2001-10-16

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Magnevist
    Dosage: unk
    Start date: 2003-09-25
    End date: 2003-09-25

Omniscan
    Dosage: 50 ml, once
    Start date: 2003-09-30
    End date: 2003-09-30

Magnevist
    Indication: Angiogram

Omniscan
    Dosage: daily dose 40 ml
    Start date: 2002-11-01
    End date: 2002-11-01

Omniscan
    Dosage: 0.2mmol/kg
    Start date: 2003-09-27
    End date: 2003-09-27

Omniscan
    Dosage: 0.1mmol/kg
    Start date: 2003-10-03
    End date: 2003-10-03

Other drugs received by patient: Simvastatin; Coumadin; Avapro; Maxidex; Claforan; Omnipaque 140; Metoprolol Tartrate; Enalapril Maleate; Chlorothiazide; Furosemide; Moduretic 5-50; Cozaar; Lasix; Magnesium Oxide; Potassium Chloride; Benadryl; Nifedipine; Sevelamer; Potassium Chloride; Spironolactone; Epogen; Iron Supplement; Omnipaque 140; Clonidine; Flonase



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Skin Lesion, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Muscular Weakness, Hypoaesthesia, DRY Skin, Skin Hypertrophy, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Plaque, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk unk, once
    Indication: Renal Scan
    Start date: 2005-08-25
    End date: 2005-08-25

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Other drugs received by patient: Pravachol; Sodium Citrate; Kayexalate; Oxycodone HCL; Aspirin; Prednisone; Calcitonin Salmon; Zaroxolyn; MS Contin; Lexapro; Lisinopril; Coumadin; Pentamidine; Compazine; Spiriva; Ativan; Norvasc; Lasix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Flagyl; Calcitriol; Labetalol HCL; Phoslo; Normodyne; Lopressor; Thiamine; Cytoxan; Wellbutrin; Viagra; Heparin; Trazodone HCL; Protonix; Darbepoetin Alfa; Fosamax; Folic Acid; Albuterol; Acetaminophen; Magnesium Oxide; Mirapex



Possible Omniscan side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Soft Tissue Disorder, Pain, Skin Hyperpigmentation, Upper Extremity Mass, Erythema, Joint Stiffness, Myosclerosis, Muscle Fatigue, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Proteinuria, Oedema, Musculoskeletal Stiffness, Injury, Renal Failure Acute, Renal Cortical Necrosis, Pain in Extremity, Musculoskeletal Pain, Rash Papular, Skin Disorder, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, Stress, Renal Failure Chronic, Emotional Distress, Anxiety, Burning Sensation, Limb Discomfort, Dysstasia, Arthralgia, Rash Erythematous, Renal Tubular Necrosis, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Start date: 2005-05-23

Magnevist
    Dosage: daily dose 20 ml
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2007-09-05
    End date: 2007-09-05

Magnevist
    Dosage: unk
    Start date: 2004-10-07

Omnipaque 140
    Dosage: 150 ml, unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-09-30
    End date: 2004-09-30

Omniscan

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-10-01

Hypaque-M [meglumine Amidotrizoate]
    Dosage: unk
    Administration route: Oral
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-06
    End date: 2004-10-06

Magnevist
    Dosage: unk
    Start date: 2005-05-09

Prohance

Magnevist
    Dosage: unk
    Start date: 2004-11-18

Optimark

Magnevist
    Dosage: unk
    Start date: 2005-05-26

Multihance

Other drugs received by patient: Immune Globulin NOS; Lopressor; Epogen; Midodrine Hydrochloride; Cytoxan; Iron; Gengraf; Xanax; Calcium +vit D; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Valcyte; Coumadin; Contrast Media; Renagel; Ferrous Sulfate TAB; Lisinopril; Norvasc; Prednisone; Marijuana; Cyclobenzaprine; Gabapentin; Lasix; Sensipar; Contrast Media; Contrast Media; Mycophenolate Mofetil (Cellcept)



Possible Omniscan side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo



Possible Omniscan side effects in 34 year old male

Reported by a lawyer from United States on 2012-04-30

Patient: 34 year old male

Reactions: Pain, Joint Contracture, Skin Hyperpigmentation, Joint Range of Motion Decreased, Fibrosis, Depression, Muscular Weakness, Skin Induration, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Skin Hypertrophy, Skin Tightness, Skin Plaque, Emotional Distress, Anxiety, Insomnia, Gait Disturbance

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-01-11
    End date: 1999-01-11

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-15
    End date: 2006-08-15

Other drugs received by patient: Oxycodone HCL; Venlafaxine; Nephrox [aluminium Hydroxide]; Calcium Acetate; Lisinopril; Coreg; Metoprolol Tartrate; Sensipar; Nifedipine; Lactulose; Aspirin; Rena-Vite; Accupril; Coumadin; Omeprazole; Fosrenol; EPO; Alprazolam; Norvasc; Chromagen [ascorbic Acid,cyanocobalamin,ferrous Fumarate,folic ACI; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Omniscan side effects in 64 year old male

Reported by a lawyer from United States on 2012-04-19

Patient: 64 year old male

Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Anxiety, Emotional Distress, Skin Lesion, Injury, Mobility Decreased

Drug(s) suspected as cause:
Omniscan
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Magnevist
    Start date: 2003-02-27
    End date: 2003-02-27

Multihance
    Indication: Product Used FOR Unknown Indication

Magnevist
    Indication: Product Used FOR Unknown Indication
    Start date: 2001-01-31
    End date: 2001-01-31

Omniscan
    Start date: 2003-02-27
    End date: 2003-02-27

Prohance
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nitroglycerin; Lanoxin; Coumadin; Metoprolol Tartrate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014